Ginsenoside Rh1

Ginsenoside Rh1 (Prosapogenin A2) inhibits the expression of PPAR-γ, TNF-α, IL-6, and IL-1β.

Product Specifications

CAS Number

[63223-86-9]

Product Name Alternative

Prosapogenin A2; Sanchinoside B2; Sanchinoside Rh1

UNSPSC

12352005

Hazard Statement

H302

Target

Endogenous Metabolite; Interleukin Related; PPAR; TNF Receptor

Type

Natural Products

Related Pathways

Apoptosis; Cell Cycle/DNA Damage; Immunology/Inflammation; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor

Applications

COVID-19-anti-virus

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/Ginsenoside-Rh1.html

Purity

98.72

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

C[C@@]([C@@]12C)(C[C@H](O[C@]([C@@H]([C@@H](O)[C@@H]3O)O)([H])O[C@@H]3CO)[C@@]4([H])C5(C)C)[C@@](C[C@@H](O)[C@]1([H])[C@]([C@@](C)(O)CC/C=C(C)/C)([H])CC2)([H])[C@]4(CC[C@@H]5O)C

Molecular Formula

C36H62O9

Molecular Weight

638.87

Precautions

H302

References & Citations

[1]Gu W, et al. Ginsenoside Rh1 ameliorates high fat diet-induced obesity in mice by inhibiting adipocyte differentiation. Biol Pharm Bull. 2013;36 (1) :102-7.